HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 81 filers reported holding HARVARD BIOSCIENCE INC in Q3 2013. The put-call ratio across all filers is 1.93 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,573 | -24.6% | 1,063,857 | -3.7% | 0.02% | -24.0% |
| Q2 2023 | $6,067 | +30.8% | 1,105,253 | 0.0% | 0.02% | +25.0% |
| Q1 2023 | $4,640 | +51.6% | 1,105,253 | 0.0% | 0.02% | +33.3% |
| Q4 2022 | $3,061 | -99.9% | 1,105,253 | +2.5% | 0.02% | 0.0% |
| Q3 2022 | $2,760,000 | -26.9% | 1,078,379 | +2.8% | 0.02% | -21.1% |
| Q2 2022 | $3,777,000 | -43.0% | 1,048,829 | -1.7% | 0.02% | -29.6% |
| Q1 2022 | $6,626,000 | -17.4% | 1,067,314 | -6.2% | 0.03% | -10.0% |
| Q4 2021 | $8,018,000 | +0.5% | 1,137,908 | -0.5% | 0.03% | 0.0% |
| Q3 2021 | $7,976,000 | -11.0% | 1,143,330 | +6.3% | 0.03% | -11.8% |
| Q2 2021 | $8,961,000 | +60.9% | 1,075,657 | +5.5% | 0.03% | +54.5% |
| Q1 2021 | $5,570,000 | +18.4% | 1,019,865 | -7.0% | 0.02% | +22.2% |
| Q4 2020 | $4,704,000 | +43.4% | 1,096,642 | +0.6% | 0.02% | +28.6% |
| Q3 2020 | $3,281,000 | -3.9% | 1,089,838 | -1.0% | 0.01% | -6.7% |
| Q2 2020 | $3,414,000 | +43.9% | 1,101,377 | +2.7% | 0.02% | +7.1% |
| Q1 2020 | $2,372,000 | -26.6% | 1,071,962 | +1.1% | 0.01% | -6.7% |
| Q4 2019 | $3,233,000 | -2.8% | 1,060,469 | -2.0% | 0.02% | +7.1% |
| Q3 2019 | $3,327,000 | +58.2% | 1,081,772 | +2.8% | 0.01% | +40.0% |
| Q2 2019 | $2,103,000 | -36.7% | 1,052,028 | +36.5% | 0.01% | -28.6% |
| Q1 2019 | $3,322,000 | +29.2% | 770,735 | -4.7% | 0.01% | +7.7% |
| Q4 2018 | $2,571,000 | -42.7% | 808,949 | -5.3% | 0.01% | -31.6% |
| Q3 2018 | $4,484,000 | -1.7% | 854,599 | +0.2% | 0.02% | -5.0% |
| Q2 2018 | $4,561,000 | +7.5% | 852,896 | +0.6% | 0.02% | +11.1% |
| Q1 2018 | $4,242,000 | +82.0% | 848,014 | +20.0% | 0.02% | +80.0% |
| Q4 2017 | $2,331,000 | -12.6% | 706,544 | -0.5% | 0.01% | -16.7% |
| Q3 2017 | $2,666,000 | +42.1% | 709,755 | -3.5% | 0.01% | +50.0% |
| Q2 2017 | $1,876,000 | -2.4% | 735,569 | -0.4% | 0.01% | -11.1% |
| Q1 2017 | $1,922,000 | -17.2% | 738,731 | -3.0% | 0.01% | -18.2% |
| Q4 2016 | $2,320,000 | +12.0% | 761,735 | 0.0% | 0.01% | +10.0% |
| Q3 2016 | $2,072,000 | -0.8% | 761,735 | +4.4% | 0.01% | -9.1% |
| Q2 2016 | $2,088,000 | -2.3% | 729,779 | +3.1% | 0.01% | 0.0% |
| Q1 2016 | $2,138,000 | -11.1% | 707,818 | +2.2% | 0.01% | -15.4% |
| Q4 2015 | $2,405,000 | -10.9% | 692,790 | -2.9% | 0.01% | -13.3% |
| Q3 2015 | $2,698,000 | -46.1% | 713,756 | -18.8% | 0.02% | -37.5% |
| Q2 2015 | $5,010,000 | -2.3% | 878,953 | -0.2% | 0.02% | 0.0% |
| Q1 2015 | $5,127,000 | +3.7% | 880,929 | +1.0% | 0.02% | +9.1% |
| Q4 2014 | $4,946,000 | +38.8% | 871,829 | 0.0% | 0.02% | +29.4% |
| Q3 2014 | $3,564,000 | +66.9% | 871,829 | +85.9% | 0.02% | +70.0% |
| Q2 2014 | $2,136,000 | +317.2% | 468,955 | +333.9% | 0.01% | +233.3% |
| Q1 2014 | $512,000 | +21.6% | 108,073 | +20.8% | 0.00% | +50.0% |
| Q4 2013 | $421,000 | -25.6% | 89,480 | -16.8% | 0.00% | -50.0% |
| Q3 2013 | $566,000 | – | 107,603 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Harvey Partners, LLC | 1,020,036 | $7,120,000 | 5.32% |
| Portolan Capital Management | 2,358,010 | $16,459,000 | 1.20% |
| Acuitas Investments, LLC | 375,836 | $2,623,000 | 1.14% |
| Parkman Healthcare Partners LLC | 475,367 | $3,318,000 | 0.84% |
| Adirondack Research & Management Inc. | 90,020 | $628,000 | 0.76% |
| Archon Capital Management LLC | 736,236 | $5,139,000 | 0.73% |
| BARD ASSOCIATES INC | 294,697 | $2,057,000 | 0.70% |
| PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 1,621,775 | $11,320,000 | 0.65% |
| GLOBEFLEX CAPITAL L P | 268,466 | $1,874,000 | 0.41% |
| Monarch Partners Asset Management LLC | 330,083 | $2,304,000 | 0.34% |